95
Views
3
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Natalizumab in multiple sclerosis: proceed with caution?

POLMAN CH, O’CONNOR PW, HAVRDOVA E et al.: A randomised, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. (2006) 354:899-910, RUDICK RA, STUART WH, CALABRESI PA et al.: Natalizumab plus interferon-b1a for relapsing multiple sclerosis. N. Engl. J. Med. (2006) 354:911-923, and YOUSRY TA, MAJOR EO, RYSCHKEWITSCH C et al.: Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N. Engl. J. Med. (2006) 354:924-933.

Pages 1675-1678 | Published online: 28 Jul 2006

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.